BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Telix Secures FDA Approval for Gozellix® to Expand PSMA-PET Imaging Access in Prostate Cancer

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administrat...

March 21, 2025 | News

Advanced Instruments to Acquire Nova Biomedical, Creating a Global Life Science Tools Powerhouse

Patricia Industries' subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, announ...

March 20, 2025 | News

Porton Advanced and Eureka Therapeutics Partner to Advance Next-Gen T-Cell Therapies

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleas...

March 20, 2025 | News

Telix and R2PHARMA Secure ANVISA Approval for Illuccix®, Expanding PSMA-PET Imaging in Brazil

Telix Pharmaceuticals Limited announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or 'ANVISA') has approv...

March 19, 2025 | News

Azurity Pharmaceuticals Completes Acquisition of Covis Group, Expanding Global Footprint and Therapeutic Portfolio

Azurity Pharmaceuticals ("Azurity") announced the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from e...

March 17, 2025 | News

C2N Diagnostics Secures $10M Investment from Samsung to Expand Alzheimer’s Blood Biomarker Testing

-C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced a $...

March 14, 2025 | News

Insilico Medicine Secures $110M Series E to Advance AI-Powered Drug Discovery and Clinical Innovations

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully s...

March 14, 2025 | News

Celltrion Launches STEQEYMA®, a Biosimilar to STELARA®, in the U.S. at an 85% Lower WAC List Price

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as the reference produc...

March 13, 2025 | News

SK bioscience Ships 750,000 Influenza Vaccine Doses to Southeast Asia and Latin America

750,000 doses of influenza vaccine to be supplied to Southeast Asia and Latin America in the first half of the year. Expanded exports markets ensure yea...

March 12, 2025 | News

Japan Grants Orphan Drug Designation to Lundbeck’s Amlenetug for Multiple System Atrophy

The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetu...

March 11, 2025 | News

SPRIM Global Investments and OneIM Launch $300M Joint Venture to Accelerate Clinical Trial Financing

SPRIM Global Investments ("SGI"), a global investment firm specializing in clinical-stage life sciences and pharma services based in Singapore, and On...

March 11, 2025 | News

Gan & Lee Initiates Phase 2 Trial of Bofanglutide, the First GLP-1 Mono-Agonist to Challenge Tirzepatide in Weight Management

Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the first participant has been successfully dosed in a P...

March 11, 2025 | News

Nona Biosciences Unveils AI-Powered Hu-mAtrIx™ Platform to Transform Antibody Discovery

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced to unveil its innovative AI-...

March 10, 2025 | News

Merck Reports Strong 2024 Growth with €21.2 Billion in Sales, Projects Continued Expansion in 2025

Merck, a leading science and technology company, has delivered profitable growth in fiscal year 2024, demonstrating resilience and strategic execution acro...

March 07, 2025 | Company results

Stay Connected